Bionano
Hannah Mamuszka is a seasoned healthcare executive with extensive experience in precision medicine and business development. As the Founder and CEO of Alva10 since March 2016, Mamuszka focuses on leveraging technology to enhance patient treatment and reduce healthcare costs. Concurrently, Mamuszka serves as Managing Director at 10Edison Capital, guiding investments in early-stage diagnostic companies. Other notable roles include Founding Member at Chief, Advisory Board Member for the Carolina Health Informatics Program, and Board Member at Bionano Genomics, Inc. and Circle Cardiovascular Imaging. Mamuszka's previous experience includes vital positions at Exosome Diagnostics and Exiqon, where significant contributions to pharmaceutical alliances and milestone transactions were achieved. Educational credentials include degrees from Harvard University and the University of Maryland.
This person is not in any teams
This person is not in any offices
Bionano
1 followers
At Bionano, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture into uncharted territory to look for answers. We welcome the curious and provide a place where those who are not satisfied with the status quo can feel at home. Our next-generation genome mapping and analysis tools help researchers see true genome structure to fill in what’s missing from sequencing-based data. Saphyr™, our high-speed, high-throughput whole genome mapping solution, offers unmatched structural variation discovery capabilities and the ability to construct the most complete genome assemblies. At Bionano, we are invested in the success of our customers and users around the world, and are dedicated to supporting them with the tools, resources and support they need to achieve their goals and make a real impact on improving quality of life for all.